» Articles » PMID: 35335924

Mineralizing Gelatin Microparticles As Cell Carrier and Drug Delivery System for SiRNA for Bone Tissue Engineering

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Mar 26
PMID 35335924
Authors
Affiliations
Soon will be listed here.
Abstract

The local release of complexed siRNA from biomaterials opens precisely targeted therapeutic options. In this study, complexed siRNA was loaded to gelatin microparticles cross-linked (cGM) with an anhydride-containing oligomer (oPNMA). We aggregated these siRNA-loaded cGM with human mesenchymal stem cells (hMSC) to microtissues and stimulated them with osteogenic supplements. An efficient knockdown of chordin, a BMP-2 antagonist, caused a remarkably increased alkaline phosphatase (ALP) activity in the microtissues. cGM, as a component of microtissues, mineralized in a differentiation medium within 8-9 days, both in the presence and in the absence of cells. In order to investigate the effects of our pre-differentiated and chordin-silenced microtissues on bone homeostasis, we simulated in vivo conditions in an unstimulated co-culture system of hMSC and human peripheral blood mononuclear cells (hPBMC). We found enhanced ALP activity and osteoprotegerin (OPG) secretion in the model system compared to control microtissues. Our results suggest osteoanabolic effects of pre-differentiated and chordin-silenced microtissues.

Citing Articles

Research hotspots and trends of mesenchymal stem cell-derived extracellular vesicles for drug delivery: a bibliometric and visualization analysis from 2013 to 2023.

Zhao T, Mu Y, Deng H, Liang K, Zhou F, Lin Q Front Cell Dev Biol. 2024; 12:1412363.

PMID: 39539963 PMC: 11557358. DOI: 10.3389/fcell.2024.1412363.


.

Zhang Y, Luo Y, Zhao J, Zheng W, Zhan J, Zheng H Acta Pharm Sin B. 2024; 14(1):110-132.

PMID: 38239237 PMC: 10792979. DOI: 10.1016/j.apsb.2023.08.024.


Biopolymer Micro/Nanogel Particles as Smart Drug Delivery and Theranostic Systems.

Fernandes S, Aguirre G Pharmaceutics. 2023; 15(8).

PMID: 37631274 PMC: 10457921. DOI: 10.3390/pharmaceutics15082060.


New Hope for Treating Intervertebral Disc Degeneration: Microsphere-Based Delivery System.

Guo T, Zhang X, Hu Y, Lin M, Zhang R, Chen X Front Bioeng Biotechnol. 2022; 10:933901.

PMID: 35928951 PMC: 9343804. DOI: 10.3389/fbioe.2022.933901.

References
1.
Li Y, Fan L, Liu S, Liu W, Zhang H, Zhou T . The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. Biomaterials. 2013; 34(21):5048-58. DOI: 10.1016/j.biomaterials.2013.03.052. View

2.
Nakamura T, Nakamura-Takahashi A, Kasahara M, Yamaguchi A, Azuma T . Tissue-nonspecific alkaline phosphatase promotes the osteogenic differentiation of osteoprogenitor cells. Biochem Biophys Res Commun. 2020; 524(3):702-709. DOI: 10.1016/j.bbrc.2020.01.136. View

3.
Suhorutsenko J, Oskolkov N, Arukuusk P, Kurrikoff K, Eriste E, Copolovici D . Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo. Bioconjug Chem. 2011; 22(11):2255-62. DOI: 10.1021/bc200293d. View

4.
Neto M, Oliveira M, Mano J . Microparticles in Contact with Cells: From Carriers to Multifunctional Tissue Modulators. Trends Biotechnol. 2019; 37(9):1011-1028. DOI: 10.1016/j.tibtech.2019.02.008. View

5.
Oryan A, Kamali A, Moshiri A, Baghaban Eslaminejad M . Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?. Cells Tissues Organs. 2017; 204(2):59-83. DOI: 10.1159/000469704. View